ACAD - Company ID 0001070494
The table below shows ACADIA PHARMACEUTICALS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $177.69M | $319.59M | $188.66M | $114.85M | $147.44M | $326.03M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $121.46M | $98.74M | $98.27M | $62.20M | $64.37M | $48.25M |
| Inventory | $111.37M | $91.69M | $40.45M | $11.56M | $14.10M | $9.68M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.06B |
| $938.32M |
| $616.13M |
| $507.94M |
| $617.82M |
| $717.62M |
| Property, plant & equipment | $7.51M | $4.21M | $4.61M | $6.02M | $8.05M | $9.16M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.56B | $1.19B | $748.96M | $587.81M | $700.12M | $782.62M |
| Accounts payable | $10.90M | $16.19M | $17.54M | $12.75M | $6.88M | $8.49M |
| Total current liabilities | $277.11M | $394.87M | $254.25M | $125.63M | $96.07M | $105.97M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $336.81M | $454.96M | $317.20M | $187.40M | $159.23M | $155.61M |
| Retained earnings | -$1.81B | -$2.20B | -$2.43B | -$2.37B | -$2.15B | -$1.99B |
| Total equity | $1.23B | $732.79M | $431.75M | $400.41M | $540.89M | $627.01M |